Boston Scientific has announced FDA approval of its new Infinion 16 Percutaneous Lead for use with the company’s Precision Plus Spinal Cord Stimulator (SCS) system. 
The Precision Plus system is used to treat chronic pain by electrically stimulating the spinal cord, and Boston Scientific claims that by providing greater coverage of the spinal cord, the Infinion 16 lead will be able to better alleviate chronic pain.
Press release: Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus™ Spinal Cord Stimulator System
Product page: Precision Plus™ SCS System